Product nameRecombinant human AK 1 protein
See all AK 1 proteins and peptides
Protein lengthFull length protein
Amino Acid Sequence
SequenceMGSSHHHHHHSSGLVPRGSHMEEKLKKTKIIFVVGGPGSGKGTQCEKIVQ KYGYTHLSTGDLLRSEVSSGSARGKKLSEIMEKGQLVPLETVLDMLRDAM VAKVNTSKGFLIDGYPREVQQGEEFERRIGQPTLLLYVDAGPETMTQRLL KRGETSGRVDDNEETIKKRLETYYKATEPVIAFYEKRGIVRKVNAEGSVD SVFSQVCTHLDALK
Molecular weight24 kDa including tags
Amino acids1 to 194
TagsHis tag N-Terminus
- Anti-AK 1 antibody [OTI19G4] (ab117862)
- Anti-AK 1 antibody [EPR7082] (ab126743)
- Anti-AK 1 antibody [EP7083] (ab138504)
- Anti-AK 1 antibody (ab152117)
- Anti-6X His tag® antibody [HIS.H8] (ab18184)
- Anti-6X His tag® antibody [4D11] (ab5000)
- Anti-AK 1 antibody (ab71621)
- Anti-6X His tag® antibody - ChIP Grade (ab9108)
Our Abpromise guarantee covers the use of ab167983 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Biological activitySpecific activity: > 6.0 units/ml. One unit will convert 2.0 µmoles of ADP to ATP + AMP per minute at pH 7.5 at 25
Purity>95% by SDS-PAGE .
Previously labelled as Adenylate Kinase 1.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
Constituents: 0.32% Tris HCl, 10% Glycerol
This product is an active protein and may elicit a biological response in vivo, handle with caution.
- Adenylate kinase 1
- Adenylate kinase isoenzyme 1
- Adenylate kinase soluble
FunctionCatalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Small ubiquitous enzyme involved in energy metabolism and nucleotide synthesis that is essential for maintenance and cell growth.
Involvement in diseaseDefects in AK1 are the cause of hemolytic anemia due to adenylate kinase deficiency [MIM:612631].
Sequence similaritiesBelongs to the adenylate kinase family.
- Information by UniProt
ab167983 has not yet been referenced specifically in any publications.